MYPLENZIA

Serial Number 99094229
802

Registration Progress

Application Filed
Mar 20, 2025
Under Examination
Approved for Publication
Jun 17, 2025
Published for Opposition
Jun 17, 2025
Registered

Basic Information

Serial Number
99094229
Filing Date
March 20, 2025
Published for Opposition
June 17, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
802
Status Date
Jul 1, 2025
Application
Pending
Classes
005

Rights Holder

STEALTH BIOTHERAPEUTICS INC.

03
Address
123 Highland Ave, Suite 201
Needham, MA 02494

Ownership History

STEALTH BIOTHERAPEUTICS INC.

Original Applicant
03
Needham, MA

STEALTH BIOTHERAPEUTICS INC.

Original Applicant
03
Needham, MA

STEALTH BIOTHERAPEUTICS INC.

Owner at Publication
03
Needham, MA

STEALTH BIOTHERAPEUTICS INC.

Owner at Publication
03
Needham, MA

Legal Representation

Attorney
Tricia L. Schulz

Application History

18 events
Date Code Type Description
Jul 1, 2025 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Jul 1, 2025 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 17, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 12, 2025 DOCK D ASSIGNED TO EXAMINER
May 12, 2025 DOCK D ASSIGNED TO EXAMINER
Mar 20, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 20, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2025 NWAP I NEW APPLICATION ENTERED
Mar 20, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
Mar 20, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities

Classification

International Classes
005